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Predisposition to hypertension: Risk factor for nephropathy and hyper-
tension in IDDM. Less than a quarter of the patients with juvenile-onset
IDDM develop diabetic nephropathy during the first 20 years of
diabetes. To study the determinants of this complication, we selected
patients who had come with newly diagnosed IDDM to the Joslin Clinic
between 1967 to 1972, and we examined them in 1986 to 1988, that is, 15
to 21 years after onset of diabetes. Using a case control design we
compared three groups of cases, that is, advanced nephropathy (N =
43), only microalbuniinuria (N = 41), and hypertension alone (N = 17),
with a group of controls who remained normoalbuminuric and nor-
motensive despite the long duration of IDDM (N = 61). In comparison
with controls, patients with advanced nephropathy had more parents
with hypertension (odds ratio 3.8), higher Vmax values of Na/Li coun-
tertransport in red blood cells (odds ratio 10.0 for the highest tertile),
and higher mean arterial pressure during adolescence and early adult-
hood (odds ratio 3.1 for those above the median). They also had
significantly poorer glycemic control during their first 12 years of
diabetes. Patients with hypertension alone were similar to those with
advanced nephropathy with regard to markers of predisposition to
hypertension but differed from them with regard to glycemic control,
having the best glycemic control of all the study groups. Patients who
developed only microalbuminuria during 15 to 21 years of IDDM (some
of whom will progress to overt proteinuria later) did not differ signifi-
cantly from controls with regard to predisposition to hypertension. In
conclusion, predisposition to hypertension is a major risk factor for the
development of advanced diabetic nephropathy and essential hyperten-
sion during the first 20 years of IDDM.
Less than half of the patients with juvenile-onset insulin-
dependent diabetes mellitus (IDDM) develop advanced diabetic
nephropathy [1, 21. The incidence of this complication is nil in
the first five years of IDDM, peaks in the second decade of
diabetes and declines thereafter, Why nephropathy develops in
only a subset of IDDM patients is unknown. Moreover, the
factors that determine development of an advanced stage of it
within the first 20 years of IDDM as compared to a later
development of it are also unknown F 2—4].
In a recent report based on the first half of the study group to
be examined, we demonstrated that development of overt
proteinuria in the first 20 years of IDDM is closely related to the
presence of predisposition to essential hypertension [5]. Due to
the small sample size we were not able to address two related
issues in that report. One is whether predisposition to hyper-
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tension contributes to the occurrence of microalbuminuria in
patients with IDDM for 15 to 20 years. These are the patients
most at risk of progressing to overt proteinuria in the third and
fourth decades of diabetes. The second is whether development
of essential hypertension without nephropathy in patients with
IDDM is related to the same markers of predisposition to
hypertension as development of hypertension together with
overt proteinuria.
This report examines the occurrence of three outcomes
(overt proteinuria, microalbuminuria, and essential hyperten-
sion) in the total study group during the first 20 years of IDDM
in relation to three indices of predisposition to essential hyper-
tension: parental hypertension [6, 7], adolescent blood pressure
[8], and activity of Na/Li countertransport in red blood cells [9].
Methods
Study group
From 1986 to 1988 we conducted a case control study to
determine factors associated with the development of early-
onset proliferative diabetic retinopathy. Taking into account
data from our previous studies [2, 10, 11], this study was
designed so that the determinants of diabetic nephropathy and
cardiovascular autonomic neuropathy could be investigated as
well. For this purpose, we examined an inception cohort of
IDDM patients 15 to 21 years after the onset of diabetes
(defined as immediately after the incidence rate of proteinuria
peaks), and selected for further study all cases with advanced
proliferative retinopathy and a random sample of those who had
no severe eye complications of which they were aware. This
sampling procedure allowed us to obtain a random sample of
patients without nephropathy and random samples of patients
with diabetic nephropathy (in various stages) or hypertension
alone. The findings with regard to associations between prolif-
erative retinopathy and various stages of diabetic nephropathy,
hypertension, and autonomic neuropathy have been published
elsewhere [12].
The inception cohort was selected from a roster of all
individuals who had their first visit to the Joslin Clinic between
January 1, 1967, and December 31, 1972. As members of the
inception cohort we included all patients who were Caucasian
and, at the time of the first visit, were under the age of 21,
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resided in Massachusetts, and had IDDM for less than two
years.
Of the 599 individuals meeting these criteria, 111 moved out
of New England, 10 died and 33 were untraced as of December
31, 1986. The remaining 445 patients were mailed a detailed
questionnaire to ascertain their retinopathy status. Four hun-
dred twenty-eight responded, among whom 83 reported a
diagnosis of severe eye lesions and laser treatment. All of these
patients were invited for a special examination in 1986 to 1988,
as were 135 patients randomly selected from those who did not
report proliferative retinopathy.
Fifty-nine (71%) of the patients with self-reported prolifera-
tive retinopathy and 103 (76%) of the patients who did not
report severe eye lesions or laser treatment participated in the
day-long special examination. Nonparticipants did not differ
from participants with regard to age, sex, or duration of
diabetes, All subjects agreed to participate in the study by
giving informed consent. The protocol was approved by the
Committee on Human Studies of the Joslin Diabetes Center.
Biochemical measurements and physical examination
Levels of blood glucose, hemoglobin Al, and serum creati-
nine were measured in fasting venous blood obtained on the day
of the special examination [51. Height and weight were mea-
sured with the subjects not wearing shoes. Systolic and dias-
tolic (fifth Korotkoff sound) blood pressures were obtained by
averaging two supine blood pressure measurements taken with
a standard cuff five minutes apart after the subject had been
supine for at least five minutes.
Cation content and Vmax of Na/Li CTT in red blood cells
were measured in fasting venous blood according to methods
previously described [5, 13]. To test the stability of the mea-
surements of Vmax of NaJL1 CTT in red blood cells in IDDM
individuals, the measurement was repeated in 23 study patients
6 to 24 months later. The correlation between the values was
0.90 even though the patients varied with regard to glycemic
control and level of blood pressure, and the measurement!s were
performed by a different person, By contrast, large decreases in
Vmax of Na/Ci CTT were observed in two patients who were
studied while on dialysis and again after receiving renal trans-
plants (0.55 to 0.15 and 0.50 to 0.20 mmol/liter cell/hr). Curi-
ously, the two patients who had kidney transplants before
recruitment into the study also had low values for Na/Li CTT
(0.13 and 0.25). In the analysis in this report, only first mea-
surements have been used.
Determination of nephropathy
After insulin injection and breakfast, each patient, after
voiding, drank 250 ml of water every half hour for three hours
and collected all the urine. During this time patients remained
seated except to void. The total volume of urine was recorded
and the concentration of albumin determined by radioimmuno-
assay (kit supplied by Diagnostic Corporation) [141. The albu-
min excretion rate (AER) was computed and expressed as
micrograms per minute. During the three hour urine collection
patients were interviewed with regard to their medical history
and antihypertensive medications.
Parental hypertension
A questionnaire was mailed to the parents of the patients in
the study to determine whether the parents had a history of
hypertension and if so the age at onset. Hypertension was
considered to be present if a parent reported hypertension
diagnosed by a physician before the age of 60 years and
treatment with antihypertensive medications. The choice of age
of 60 years was arbitrary but was influenced by the fact that less
than half the parents exceeded that age. If a parent was
deceased, the age of death was obtained and information about
the hypertension status was sought from the surviving spouse.
If both were deceased, or data could not be obtained, the
information was considered unavailable.
Bloodpressure during adolescence and early adulthood
To determine blood pressure levels, all blood pressure read-
ings taken during visits to the Joslin Clinic were abstracted from
the patients' medical records. For patients who had IDDM
diagnosed before age 13, blood pressure readings between age
13 and 20 were used. For all patients who had IDDM diagnosed
after age 13, blood pressure readings during the first eight years
of 10DM were used. For patients who had three or more
readings, mean arterial pressure was computed at each clinic
visit and then averaged over all visits (the average number of
visits per patient was 12). The choice of three visits as the
minimum was arbitrary, but the pattern of results were un-
changed regardless of whether 3, 5 or 7 measurements was set
as the minimum. Mean arterial pressure was computed accord-
ing to the formula: diastolic blood pressure + 0.33 (systolic
blood pressure — diastolic blood pressure).
Index of glycemic control
An index of past glycemic control was calculated from the
blood glucose levels recorded at each visit to the Joslin Clinic.
An index of hyperglycemia was estimated if a patient had at
least nine clinic visits during the first 12 years of diabetes. The
index was computed as described in our previous study [2].
Patients with fewer visits were considered clinic non-attenders,
Definition of study groups
The subjects were divided into four study groups. Patients
who had an AER of less than 20 g/min and blood pressure (mm
Hg) less than 140 systolic and 90 diastolic were considered
controls. Patients who had AER between 20 and 250 g/min
were considered to have microalbuminuria. The cut point 250
was used instead of the commonly used 200 g/min since there
were three patients with AER between 200 and 230 g/min, and
none between 230 and 400 g/min. Patients with an AER 250
tg/min or more were considered to have advanced diabetic
nephropathy, proteinuria. In this group, there were 16 individ-
uals with serum creatinine >1.5 mg/dl including seven individ-
uals on hemodialysis or with a renal transplant. Those patients
with an AER below 20 jtg/min who were on antihypertensive
medications or had a systolic or diastolic blood pressure equal-
ing or exceeding 140 or 90 mm Hg, respectively, were consid-
ered to have hypertension only. Since the study group was aged
20 to 40 years, these relatively low cut points for the definition
of hypertension were deemed to be appropriate.
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Table 1. Characteristics of study patients according to presence of four different outcomes at examination 15 to 21 years after the diagnosis of
juvenile-onset IDDM
Characteristics at the time of
examination
Controls
N = 61
Microalbuminuria
N = 41
Proteinuria
N = 43
HypertensionN = 17
Percent men 49 46 53 70
Age (years) at diagnosis of IDDM 12 5 II 5 12 4 12 5
Age (years) at examination 29 5 28 5 29 4 29 4
Percent ideal body weight 106 16 110 18 108 24 118 18
Albumin excretion rate .tgImin 7 6 94 66 2568 293l 7 5
Systolic blood pressure mm Hg 113 10 125 13 138 24 134 12
Diastolic blood pressure mm Hg 73 7 82 10 91 15 92 5
Percent on treatment for hypertension — 7 58 6
Data are presented as mean SD.
a Included in the 43 individuals with overt proteinuria were 27 with a serum creatinine <1.5 mg% and 16 with a serum creatinine 1.5 mg%
(including 7 with a renal transplant or on hemodialysis)
Table 2. Prevalence (percent) of hypertension in the parents of patients in the four study groups
Parental Controls Microalbuminuria Proteinuria Hypertension
hypertensiona N = 61 N = 39 N = 43 N = 17
Mothersb 26 23 47 47
Fathersc 21 33 39 30
One or both parents 38 46 70 71
Odds ratio 1.0 1.4 3.8 4.0
95% C.1. — 0.6—3.2 1.7—8.8 1.2—12.7
a Hypertension diagnosed before age 60. Median age at the time of examination or at age of death was 59 years for mothers 58 for fathers and
these medians were similar in all study groups. For 2 patients with microalbuminuria, no information is available on either parent.
b The proportion of mothers who died before age 60 was 5%, 2%, 9% and 0% in controls, microalbuminuria, proteinuria and hypertension
groups, respectively.
C The proportion of fathers who died before age 60 was 11%, 17%, 16%, and 18% in controls, microalbuminuria, proteinuria and hypertension
groups, respectively.
Statistics
Data were analyzed using a case control approach [15]. Three
groups of cases were compared with one group of controls.
Standard descriptive statistics have been used to compare the
distributions of variables among the four study groups, and chi
square tests and analysis of variance have been used to test
statistical hypotheses [16]. As the descriptive measure of asso-
ciation between risk factors and each of the outcomes, odds
ratios have been given together with 95 percent confidence
intervals [15]. These odds ratios are based on 17-year cumula-
tive incidence rates and, therefore, underestimate the relative
risk that would be obtained from a comparison of year-by-year
incidence rates [15]. The joint effects of factors identified by
univariate analyses as impacting on the development of hyper-
tension were studied by logistic analysis [16].
Results
In the group of 162 patients with juvenile-onset IDDM who
were examined 15 to 21 years after onset of diabetes, we
identified 61 who were normotensive and had no evidence of
nephropathy (controls), 41 who had microalbuminuria, 43 who
had proteinuria, and 17 who had hypertension but had no
evidence of nephropathy. Table 1 summarizes several charac-
teristics of the four study groups. At the time of examination,
the groups with microalbuminuria, overt proteinuria or hyper-
tension did not differ from controls with regard to age at onset
of diabetes or age at examination. Moreover, while the group
with hypertension had a higher proportion of males and a higher
percent ideal body weight than other groups, the differences
among groups for these variables were also not statistically
significant. Overall, 40% had never smoked cigarettes, 24%
were ex-smokers, 36% were current smokers, and these pro-
portions did not vary significantly among the four groups (data
not shown).
Mean systolic and mean diastolic blood pressures were
highest in the group with proteinuria and the group with
hypertension alone, lowest in the control group, and interme-
diate in the group with microalbuminia. To explore whether the
etiology of hypertension which was associated with nephrop-
athy differed from the etiology of hypertension which occurred
without nephropathy, three different qualitative measures of
predisposition to hypertension were compared among the study
groups.
The first measure of predisposition to hypertension was
based on whether diagnosed hypertension was present in a
parent before age 60 (Table 2). The group with advanced
nephropathy and the group with hypertension alone had simi-
larly high frequencies of a history of parental hypertension,
almost twice the frequency in the control group. In the group
with microalbuminuria, on the other hand, the frequency of
parental hypertension was closer to the controls than to the
advanced nephropathy group. When the association was re-
expressed as odds ratios, we found that patients with a hyper-
tensive parent (one or both) had a 3.8-fold risk of advanced
diabetic nephropathy and a 4.0-fold risk of hypertension alone
in comparison with patients with normotensive parents.
The second measure of predisposition to hypertension was
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Table 3. Mean values for systolic and diastolic blood pressure and mean arterial blood pressure during adolescence and early adulthood in the
four study groupsa
Systemic blood pressure mm Hg
Controls
N = 54
Microalbuminuria
N = 35
Proteinuria
N = 33
HypertensionN = IS
Number of measurements 13 8 11 4 11 5 10 5
Systolic pressure
Diastolic pressure
Mean arterial pressure
108 7
68 482 4
110 8
70 5
83 6
ill 10
73 6'
85
119 11b
73 5
88 7b
Number with mean arterial pressure
Below mediane 27 12 8 2
Above median 27 23 25 13
Odds ratio 1.0 1.9 3.1 6.5
95% C.I. — 0.8—4.6 1,2—8.2 1.3—31.6
Data are presented as mean SD.
a Omitted are 25 patients with less than 3 measurements of blood pressure available during the adolescent/young adult age interval: 7 controls,
6 with microalbuminuria, 10 with proteinuria, and 2 with hypertension only.b p < 0.02 in comparison with the control group.
C Mean arterial blood pressure = (pulse pressure)/3 + diastolic blood pressure. Median of the distribution of mean arterial pressure in the control
group was 81.1 mm Hg.
Table 4. Sodium and potassium content and Vmax of Na/Li countertransport in red cells of IDDM patients in the four study groupsa
Controls
N=34
Microalbuminuria
N=26
Proteinuria
N=29 HypertensionN=l2
Intracellular Na mmol/liter RBC
Intracellular K mmol/Iiter RBC
Vmax of Na/Li eountertransport
mmol/liter RBC/hr
8.8 2.0
101 13
0.36 0.20
9.5 2.5
101 10
0.43 0.18
9.3 1.6
103 9
0.49 024b
8.3 1.396 9
0.46 0.18
Data are presented as mean SD.
a Omitted are 61 patients for whom Na/Li countertransport was not measured: 27 controls, 15 with microalbuminuria, 14 with proteinuria, and
5 with hypertension only.
b p < 0,02 in comparison with the control group
the blood pressure level during adolescence and early adult-
hood, For each patient, blood pressure measurements were
averaged over the ages 13 to 20 years for those who developed
diabetes before age 13, and during the first eight years of IDDM
for those who developed diabetes after age 13. The distributions
of these averages were summarized in Table 3. The group with
hypertension alone (without nephropathy) had the highest sys-
tolic blood pressure in comparison with the other groups.
Although the proteinuria and microalbuminuria groups had
systolic blood pressures which were intermediate between the
hypertension group and controls, the values were not signifi-
cantly different from controls. Regarding diastolic blood pres-
sures, the proteinuria group and the hypertension group had
similar values and these were 5 mm Hg higher than controls.
The microalbuminuria group had an intermediate value.
To illustrate the relationship of blood pressure during adoles-
cence and young adulthood to the development of each of the
three outcomes, the groups were subdivided at the median of
the distribution of mean blood pressure in controls in order to
compute odds ratios. Relative to patients who were below the
median, those who were above the median had 1.9 times the
risk of developing microalbuminuria, 3.1 times the risk of
developing overt proteinuria, and 6.5 times the risk of develop-
ing hypertension alone.
The third measure of predisposition to hypertension was the
activity of the red cell sodium-lithium countertransport (Na/Li
CTT). Mean values of sodium and potassium content and
maximum velocities of sodium-lithium countertransport in red
blood cells in the four study groups are shown in Table 4.
Intracellular Na content was slightly higher in the microalbu-
minuria and proteinuria groups than in the essential hyperten-
sion group and controls, On the other hand, the Vmax for Na/Li
CTT was significantly higher in the proteinuria group than in
controls, and was equally elevated in the essential hypertension
group. Of note is the fact that the microalbuminuria group had
an intermediate value for the mean of the Vmex of Na/Li CTT.
The strong relationship between the Vmax of Na/Li CTT and
the presence of proteinuria and hypertension is shown graphi-
cally in Figure 1. The Vmax of the Na/Li CTT distribution in the
control group was divided to thirds, and the odds ratios for the
development of each outcome were computed for each tertile.
The risk of hypertension or proteinuria increased 5- to 10-fold
with 'max of Na/Li CTT, while the risk of microalbuminuria
increased only 2- to 3-fold.
Table 5 compares various indices of glycemic control among
the four study groups. The index of hyperglycemia was based
on the frequency of severe hyperglycemia during the first 12
years of diabetes (Methods), while the level of glycosylated
hemoglobin at the time of the study examination reflected
recent control. The proteinuria group and the microalbuminuria
group had equally poor glycemic control, regardless of whether
the comparison was based on the 12 year history or current
glycohemoglobin. In striking contrast, the group with essential
hypertension had the best glycemic control at the time of
examination as well as in the past.
The relationship between the level of glycemic control during
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0.06-0.24 0.25-0.40 0.41 +
Vmax of Na/Li CU, mmo//liter cell/hr
Fig. 1. Odds ratio of developing hypertension alone (•), overt protein-
uria (A) or only microalbuminuria (I) during 15 to 21 years ofJDDM
according the tertiles of the of Na/Li CTT in red blood cells. The
ranges for the tertiles are shown on the abscissa. For hypertension
alone, the 95% confidence intervals for odds ratios for the second and
third tertiles are (0.6, 53.2) and (1.3, 19.9), respectively. The corre-
sponding confidence intervals for proteinuria are (0.6, 18.9) and (1.9,
53.5), and for microalbuminuria they are (0.5, 8.6) and (0.8, 13.2),
respectively.
the first 12 years of diabetes and the development of overt
proteinuria or microalbuminuria is illustrated in Figure 2. Odds
ratios for the development of these two outcomes during the
first 20 years of IDDM were computed according to the quar-
tiles of the distribution of the index of hyperglycemia in
controls. The risk of developing proteinuria increased in a
dose-dependent manner across the quartiles of hyperglycemia,
being 5.5 times higher in the fourth quartile (poorest glycemic
control) in comparison with the first quartile (best glycemic
control). Non-attenders in the clinic had a high risk of protein-
uria as well, similar to those in the 4th quartile. The risk of
microalbuminuria also increased with worsening glycemic con-
trol but rose only half as steeply as that for proteinuria. Data for
the development of hypertension as an outcome are not pre-
sented since the sample size was too small for dividing into
quartiles.
To test the independent contribution of each risk factor to the
development of proteinuria, logistic regression analysis was
used. The first model evaluated the joint roles of adolescent
blood pressure and glycemic control during the first 12 years of
attendance in the Clinic (Table 6). As in the univariate analyses,
the risk of proteinuria increased progressively with increasing
severity of hyperglycemia, and the relative odds of 4.9 for the
quartile with the worst glycemic control were statistically
significant in this multivariate model. After adjusting for the
level of hyperglycemia, the relative odds for the association
between adolescent blood pressure and the risk of proteinuria
was 1.9 and was still statistically significant (P = 0.04). In the
second and the third models, each of the other two measures of
predisposition to hypertension were evaluated together with the
index of glycemic control. The strong effect of poor glycemic
control remained the same in all three models. Model two
showed that the strong association with parental hypertension
persists after adjustment for glycemia, and model three demon-
strated the same for the Vmax of NaILi.
When all measures of predisposition to hypertension were
included together in the model, the total chi square for the
model increased significantly, but the relative odds for each
measure decreased somewhat. This indicated that there was
some, but not complete overlap between these measures (data
not shown). A history of hypertension in one or both parents
remained a significant (P 0.03) risk factor for proteinuria, and
the coefficient for the highest third of the distribution of Na/Li
countertransport was almost significant (P = 0.08). The asso-
ciation between adolescent blood pressure and proteinuria,
however, diminished (P > 0.10) when the other measures of
predisposition to hypertension were included. This suggests
that an association of elevated adolescent blood pressure with
nephropathy in univariate analyses (Table 3) was present be-
cause it was an indicator of predisposition to essential hyper-
tension rather than evidence that elevated systemic blood
pressure was an independent risk factor for nephropathy.
When similar models were tested for essential hypertension
we found similar associations as for proteinuria except for a
nonsignificant protective effect of poor glycemic control (data
not shown). None of the models for microalbuminuria was
statistically significant.
Discussion
Less than a quarter of the patients with juvenile-onset IDDM
develop advanced diabetic nephropathy during the first 20 years
of diabetes [1, 2]. To study the determinants of this complica-
tion, we selected patients who had come with newly diagnosed
IDDM to the Joslin Clinic between 1967 and 1972, and we
examined them from 1986 to 1988, that is, 15 to 21 years after
onset of diabetes. Using a case control design we compared
three groups of cases (those who had advanced nephropathy,
those who had only microalbuminuria, and those who had
hypertension only) with a group of controls who remained
normoalbuminuric and normotensive despite a long duration of
IDDM.
It appears that the development of advanced nephropathy in
the study cohort was strongly associated with predisposition to
essential hypertension. We demonstrated this by comparing the
frequency of three different measures of predisposition to
hypertension in cases and controls. All three measures yielded
similar results, that is, in comparison with normoalbuminuric
and normotensive controls, those who developed overt protein-
uria were more likely to have parents with hypertension, to
have high velocities of Na/Li CTT in red blood cells, and to
have higher systemic blood pressure during adolescence and
early adulthood. Interestingly, patients with overt proteinuria
had similar distributions of the indices of predisposition to
hypertension as the group who developed hypertension without
any evidence of nephropathy. In addition, we demonstrated
that the max ofNa/Li CTT determined by our method is a very
stable measurement over time in patients with IDDM. Consis-
tency has also been evident in findings in this study sample,
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Table 5. Indices of blood glucose control during the first 12 years after diagnosis of diabetes and at the time of examination in the four study
groups
Index of blood glucose
control
Controls
N = 61
MicroalbuminuriaN 41
Proteinuria
N = 43
HypertensionN = 17
First 12 years after diagnosis of diabetes
Nonattendersa % 23 24 30 17
Hyperglycemia index" 42 18 51 18" 52 18" 34 21
At examination for the study
Hemoglobin Al % 10.9 1.9 12.1 2.3c 12.2 2.0c 10.5 1.4
Insulin dose p.1kg 0.74 0.2 0.73 0.2 0.69 0,2 0.70 0.2
Data are presented as mean SD.
"Nonattenders are defined as patients with fewer than 9 clinic visits. The index was computed if a patient had 9 or more clinic visits.b P < 0.05 in comparison with controls and those with hypertension only
P < 0.01 in comparison with controls and those with hypertension only
1st 2nd 3rd 4th Non-attenders
Quartiles of index of hyperglycemia
Fig. 2. Odds ratio of developing overt proteinuria (A) or only microal-
bunünuria (•) during 15 to 21 years of IDDM according to the quartiles
of the distribution of the index of glycemic control during the first /2
years of diabetes. The lowest quartile is the reference group. The
ranges for the quartiles of the index are as follows: 0—29%, 30—42%,
43—55% and 56—85%. For proteinuria, the 95% confidence intervals for
the odds ratios for the second, third, and fourth quartiles and non-
attenders are: (0.5, 12.5), (0.7, 15.9), (1.3, 24.3), and (1.01, 18.6),
respectively. The corresponding confidence intervals for microalbumin-
uria are: (0.3, 5.5), (0.4, 7.2), (0.98, 13.0), and (0.5, 7.4), respectively.
from our first report in 1987 based on one fourth of the group
[17], to the 1988 paper based on half of the group [5], and finally
to the present report based on the total study group.
During the last few years, several authors have reported on
the association between predisposition to hypertension and
diabetic nephropathy. Viberti and coworkers [18, 19] described
findings similar to ours, and they recently demonstrated that
parents of patients with diabetic nephropathy have significantly
higher max of Na/Li CTT than parents of normoalbuminuric
IDDM patients [20], Semplicini et al showed that IDDM pa-
tients with isolated hypertension without nephropathy are more
likely to have hypertensive parents and a high max of Na/Li
CTT than normotensive and normoalbuminuric IDDM patients
[21]. Our group of patients with essential hypertension showed
similar differences from controls as those reported by Sempli-
cmi et al [21].
In a study of a group of young IDDM patients with short
duration diabetes, Chase et al found that individuals with
microalbuminuria had more hypertensive parents than those
who remained without microalbuminuria during 6.6 years of
follow-up [22]. Although statistically significant, the difference
in the prevalence of parental hypertension between groups was
small due to the young age of parents. As we demonstrated in
this report, the difference is large when parents are compared at
age 60. In contrast to our findings and the findings of these other
authors, Jensen et al have been unable to confirm the hypoth-
esis that predisposition to hypertension is a risk factor for
diabetic nephropathy in IDDM patients [23]. Their data are
consistent with ours in that they found an excess of parental
hypertension and an elevated Vmax of Na/Li CTT in cases, but
they dismiss the findings because the differences did not reach
statistical significance. The lack of statistical significance was
due, in part, to the inclusion of cases with long as well as short
duration IDDM and to inappropriate selection of a control
group [241.
The other major finding of the present study is a demonstra-
tion of the importance of glycemic control in the development
of diabetic nephropathy as compared to essential hypertension
(without nephropathy). Patients with proteinuria had poor
glycemic control whereas those with hypertension alone had
the best glycemic control of all the study groups. Since these
two groups of cases did not differ in any characteristic except
glycemic control, it follows that poor glycemic control (or its
associated factors) interacts with elevated blood pressure (or its
predisposing abnormalities) to produce diabetic nephropathy.
The fact that the risk of advanced nephropathy was more
closely associated with parental hypertension and a high Vmax
of Na/Li CTT than arterial blood pressure during early adult-
hood suggests that factors which predispose to hypertension are
more important than elevated systemic blood pressure itself.
This agrees with data from prospective studies which have
found relatively small baseline differences in systemic blood
pressure between those who develop nephropathy during fol-
low-up and those who do not [25, 26].
A question arises as to how hyperglycemia interacts with
predisposition to hypertension to induce the onset of diabetic
nephropathy. Several studies have shown that offspring of
hypertensive parents have abnormalities in renal hemodynam-
ics [27—291. Moreover, poor glycemic control can have an
impact on renal hemodynamics which is similar to that seen in
individuals with predisposition to hypertension, namely in-
creasing filtration fraction [30]. The presence of these two
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Table 6. Multiple logistic regression analysis of the contribution of measures of predisposition to hypertension to the risk of developing overt
proteinuria
Characteristic
Model I:
Adolescent
blood pressure
Model II:
Parental
hypertension
Model III:
Na/Li CTT
Re!. odds PRd. odds PRel. odds P
Index of hyperglycemia
Quartile: First 1.0 1.0 1.0
Second 2.0 2.5 2.3
Third 2.8 3.4 2.4
Fourth 4.7 0.048 5.2 0,036 4.1 0.077
Nonattenders 2.4 2.9 2.7
Adolescent mean arterial pressure
Below mediana 1.0
Above median 1.9 0.042
Parental hypertension
Neither parent 1.0
One or both parents 3.3 0.009
Vmax of Na/Li CTT mmol/L cells/hr
006,023b 1.0
0.24—0.40 2.5
0.41 & above 7.0 0.027
As noted in Tables 2 through 4, there are missing data on parental hypertension, adolescent blood pressure, and the Vmax of Na/Li CTT. We
used a multiple logistic regression model consisting of an indicator for each type of missing data to determine that there was no significant
confounding of the analysis due to missing data. These indicator variables were included in all models in Table 6, but are not shown since none
were significant.
a Since adolescent mean arterial pressure was entered as a linear term, the 25th percentile was used to represent "below median" and the 75th
percentile to represent 'above median".b The three groups represent the tertiles of the distribution of Na/Li CTT.
factors together may produce a critical increase in intraglomer-
ular pressure and the development of diabetic nephropathy
during the first 20 years of IDDM.
It should be noted that, in addition to patients with overt
proteinuria, we identified in this study a group of patients who
only have microalbuminuria after 15 to 21 years of IDDM. This
group presumably includes the individuals who will progress to
overt proteinuria during the third and fourth decade of IDDM.
Interestingly, a family history of hypertension was not strong in
this group, values of Vmax of Na/Li CTT in red blood cells were
intermediate, and blood pressure readings during late adoles-
cence and early adulthood were like those in the control group.
Mathiesen et al reported a similar lack of difference in arterial
blood pressure between patients who developed microalbumi-
nuria late in the course of IDDM in comparison with those who
remained without microalbuminuria [31]. Recently, Elving et a!
also reported a lack of difference in the Vma of Na/Li CTT in
red blood cells between normoalbuminurics and patients with
microalbuminurialproteinuria and very long duration of IDDM
[32]. In contrast, Jones et a! [33] found a significantly higher
Vmax of Na/Li CTT in patients with persistent microalbuminuria
in comparison with age- and duration-matched normoalbumin-
urics. The distribution of duration of diabetes was very large (5
to 33 years) in that study, so it is possible that the elevated Vmax
of Na/Li CTT was present only among those with duration less
than 15 years. If this were true, their results would be in
agreement with our study, but one cannot know from the results
as published.
These findings are consistent with the hypothesis that overt
proteinuria developing in the third and fourth decades of IDDM
may be determined by different factors than proteinuria occur-
ring early in the course of diabetes [2—5]. From our data two
different models can be postulated. One is that IDDM patients
with predisposition to hypertension and poor glycemic control
develop early microalbuminuria which progresses to overt
proteinuria within the first 20 years of diabetes, whereas,
patients without this predisposition but with poor glycemic
control develop microalbuminuria late in the course of diabetes
and may subsequently progress to proteinuria. The other pos-
sibility is that poor glycemic control is responsible for the
"initiation" of microalbuminuria, and those with predisposition
to hypertension have rapid progression to overt proteinuria,
whereas those without predisposition are slow progressors or
they do not progress at all. Further testing of these alternative
models is possible only in follow-up studies.
Finally, a few points should be noted regarding strengths and
weaknesses. This study was based on an inception cohort, and
members of the cohort were studied regardless of whether they
continued to attend the clinic. This provides protection against
confounding due to selective removal from the study groups.
On the other hand, there are certain weaknesses. First, we used
routine measurements of blood pressure and blood glucose
performed during visits to the clinic. These measurements were
not precise, and the resulting error diminished the differences
among the study groups and the estimated odds ratios [34].
Therefore, one may expect that when using more precise
estimates of glycemic control, such as glycosylated hemoglobin
and standardized blood pressure measurements, one would
obtain stronger relationships between the risk of advanced
diabetic nephropathy and elevated blood pressure during ado-
lescence, and early adulthood and poor glycemic control.
Second, whereas the definitions of hypertension, overt protein-
uria, and the absence of nephropathy and hypertension (con-
trols) were reliable, the definition of microalbuminuria in this
730 Barzilay et a!: Predisposition to hypertension and diabetic nephropathy
study may be less reliable. The group which we identified may
actually be a heterogeneous mixture of some lingering slow
progressors, some patients who recently developed microalbu-
minuria, and some patients who had an elevated AER by
chance.
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